Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UROVATS: Urokinase vs VATS for Childhood Empyema
NCT02165891Phase 3Unknown
- Sponsor
- Queen Fabiola Children's University Hospital
- Start
- Feb 2015
- Primary completion
- Jun 2020
- Modality
- Therapeutic Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of urokinase in pleural empyema, sponsored by Queen Fabiola Children's University Hospital. Primary endpoint: Duration of drainage. Status: unknown.
02
Drugs
urokinase
03
Conditions
pleural empyema
Beyond the preview
Go deeper on NCT02165891.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02165891.